441 - 450 of 8404 Results
Title
Year
-
RESTRICTEDTitle: Synthesis at the Interface of Chemistry and BiologyJournal Name: Accounts of Chemical ResearchPublisher: American Chemical Society (ACS)Vol: 57Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.accounts.4c00320Citation Count: 0
- Towards early diagnosis and screening of Alzheimer’s disease using frequency locked whispering gallery mode microtoroids2024OPENTitle: Towards early diagnosis and screening of Alzheimer’s disease using frequency locked whispering gallery mode microtoroidsJournal Name: npj BiosensingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s44328-024-00009-8Best OA location URL: https://www.nature.com/articles/s44328-024-00009-8.pdfCitation Count: 4
-
RESTRICTEDTitle: Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson’s diseaseJournal Name: NeuroradiologyPublisher: Springer Science and Business Media LLCVol: 66Issue #: 11Start Page: 1955End Page: 1966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00234-024-03452-6Citation Count: 1
- Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD2024OPENTitle: Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PDJournal Name: Frontiers in Digital HealthPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdgth.2024.1435693Best OA location URL: https://doi.org/10.3389/fdgth.2024.1435693Citation Count: 2
- Cell-specific expression of key mitochondrial enzymes limits OXPHOS in astrocytes of the adult human neocortex and hippocampal formation2024OPENTitle: Cell-specific expression of key mitochondrial enzymes limits OXPHOS in astrocytes of the adult human neocortex and hippocampal formationJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s42003-024-06751-zBest OA location URL: https://www.nature.com/articles/s42003-024-06751-z.pdfCitation Count: 6
- Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies2024OPENTitle: Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologiesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 385Issue #: 6711Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abm6131Best OA location URL: https://doi.org/10.1101/2024.06.23.598940Citation Count: 21
- Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification Trials2024OPENTitle: Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification TrialsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 11Start Page: 1345End Page: 1354Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14191Best OA location URL: https://doi.org/10.1002/mdc3.14191Citation Count: 0
-
OPENTitle: IAPP - oligomerisation levels in plasma of people with type 2 diabetesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-70255-3Citation Count: 0
- Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers2024OPENTitle: Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00763-6Citation Count: 7
- Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits2024OPENTitle: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficitsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 34Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adn6016Best OA location URL: https://doi.org/10.1126/sciadv.adn6016Citation Count: 8